Profile Picture

Kedar Ajit Dhole - Profile

Kedar Ajit Dhole, Director and Designated Partner, with 5 companies.

About Kedar Ajit Dhole

Kedar Ajit Dhole has 12 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Prezier Pharmaceuticals Private Limited and Askbio Pharmaceuticals Llp. Formerly with 2 companies, such as Tfb Business Solutions Private Limited and Kadsun Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.

Current Companies 3
Past Companies 2
Total Affiliations 5
Oldest Company Age 7
Companies Associated with Kedar Ajit Dhole
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Kedar Ajit Dhole?

Kedar Ajit Dhole has 12 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Prezier Pharmaceuticals Private Limited and Askbio Pharmaceuticals Llp. Formerly with 2 companies, such as Tfb Business Solutions Private Limited and Kadsun Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.

What is Kedar Ajit Dhole's role in current companies?

Kedar Ajit Dhole is associated with 3 companies as Director and Designated Partner.

What industries does Kedar Ajit Dhole specialize in?

Kedar Ajit Dhole has expertise in General Business, Healthcare.

How many years of experience does Kedar Ajit Dhole have?

Kedar Ajit Dhole has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available